TNF and cancer: In this regard, the interaction of ligands of the TNF-α (Tumor Necrosis Factor-α) family (TNF-α, FasL, TRAIL) with their respective receptors, as well as of PD-L1 (Programmed Death Ligand-1) with its receptor PD1, have been shown to mediate the docking of EVs produced by different cancer cells.